Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Anne Fung, MD
Perceive Biotherapeutics, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Sydney Retina Clinic and Day Surgery
Sydney, New South Wales, Australia
- Cerulea Clinical Trials
East Melbourne, Victoria, Australia
- Rambam Medical Center
Haifa, Israel
- Tel-Aviv Sourasky Medical Center, Ophthalmology Division
Tel Aviv, Israel
- Retina Macula Institute of Az
Scottsdale, Arizona, United States
- Retina Consultants San Diego
Poway, California, United States
- Retinal Consultants Medical Group
Sacramento, California, United States
- Ophthalmic Consultants of Boston
Boston, Massachusetts, United States
- the Retina Institute
St Louis, Missouri, United States
- Mid Atlantic Retina
Cherry Hill, New Jersey, United States
- Retina Northwest
Portland, Oregon, United States
- Black Hills Regional Eye Institute
Rapid City, South Dakota, United States
- Austin Research Center for Retina
Austin, Texas, United States
- Star Retina
Fort Worth, Texas, United States
- Retina Center of Texas
Southlake, Texas, United States
- University of Utah John A. Moran Eye Center
Salt Lake City, Utah, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 Jun 2023
- Primary completion
- 31 Oct 2027
- Completion
- 30 Jun 2028
- Last update posted
- 17 Aug 2026
- Registered enrollment
- 60
- Registry id
- NCT06087458
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.